CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones
Cachexia has been recognized as a direct cause of reduced quality of life complicating in cancer patients. Patients with pancreatic ...
Taipei, Taiwan
Zolbetuximab is being studied as a treatment for people with pancreatic cancer. Most people with pancreatic cancer...
Phase 2
Taipei, Taiwan and 135 other locations
Pancreatic cancer is difficult to diagnose early. By the time people have been diagnosed, the cancer has usually spread to ...
Phase 3
Taipei, Taiwan and 78 other locations
phosphorylase (MTAP)-deleted gastrointestinal, biliary tract, or pancreatic cancers. The study also aims to determine the safety...
Phase 1
Taipei, Taiwan and 76 other locations
The purpose of this study is to evaluate the safety and efficacy of an investigational RAS(ON) inhibitor administered as monotherapy or in combinatio...
Phase 3
Taipei, Taiwan and 48 other locations
of AZD0901 as monotherapy and in combination with anti-cancer agents in participants with locally advanced unresectable or metastatic solid ...
Phase 2
Taipei, Taiwan and 51 other locations
Cancer is a condition where cells in a specific part of body grow and reproduce uncontrollably. Non-Small Cell Lung Cancer (NSCLC) ...
Phase 1
Taipei, Taiwan and 47 other locations
This is a Phase I/II, open-label, multi-center, multi-national, dose escalation, single agent study to assess the safety, tolerability, PK, PD, immun...
Phase 2
Taipei, Taiwan and 64 other locations
The purpose of this study is to evaluate the safety, tolerability, and pharmacokinetics (PK) of escalating doses of RMC-6291 (KRAS G12C(ON) inhibitor...
Phase 1
Taipei, Taiwan and 63 other locations
This is an open-label, multicenter, global Phase 2 basket study of entrectinib (RXDX-101) for the treatment of patients with solid tumors that harbor...
Phase 2
Taipei, Taiwan and 122 other locations
Clinical trials
Research sites
Resources
Legal